Bulletin
Investor Alert

New York Markets Close in:

Syros Pharmaceuticals Inc.

NAS: SYRS

GO
/marketstate/country/us

Market open

 --Real time quotes

Oct 4, 2022, 1:13 p.m.

/zigman2/quotes/201168308/composite

$

6.60

Change

+0.66 +11.11%

Volume

Volume 102,411

Real time quotes

/zigman2/quotes/201168308/composite

Previous close

$ 5.94

$ 6.60

Change

+0.66 +11.11%

Day low

Day high

$6.16

$6.62

Open

52 week low

52 week high

$5.25

$48.00

Open
Sorry, there are no transactions available for this individual.

Officers and Executives

Dr. Nancy A. Simonian
President, Chief Executive Officer & Director
Mr. Jason Haas
Chief Financial Officer
Dr. Eric R. Olson
Chief Scientific Officer
Dr. David A. Roth
Chief Medical Officer
Ms. Kristin Stephen
Chief Development Officer
Mr. Conley Chee
Chief Commercial Officer
Dr. Richard A. Young
Director
Mr. Peter Wirth
Chairman
Mr. Mark J. Alles
Independent Director
Dr. S. Gail Eckhardt
Independent Director
Dr. Deborah L. Dunsire
Independent Director
Dr. Phillip A. Sharp
Independent Director
Ms. Marsha H. Fanucci
Independent Director
Dr. Amir H. Nashat
Independent Director
Dr. Srinivas Akkaraju
Independent Director
Link to MarketWatch's Slice.